USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Why Stem Cell Therapy?
02-Sep-2015
Global
Market Research
9AB9-00-3D-00-00
LS00078-GL-MR_16919
Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases such as cancer, heart disease, and neuro-muscular ailments among the ageing population. This research study provides an overview of the regenerative medicine industry and an insight on successful stem cell therapy treatments. It also analyses marketed products, stem cell manufacturing and funding, and the collaborative partnerships in the regenerative medicine industry.
Key Findings
Key Questions This Study Will Answer
Regenerative Medicine Industry—Where We Stand Today
Regenerative Medicine Industry—Where We Stand Today (continued)
Regenerative Medicine Industry—Key Stakeholders
Definition—Regenerative Medicine
Regenerative Medicine—Market Segmentation
Why is Regenerative Medicine Important to the Future of Healthcare?
Market Size and Growth—Regenerative Medicine
Geographical Overview for Regenerative Medicine Companies
Total Regenerative Medicine Industry
Definitions—Cell Therapy and Stem Cell Therapy
Cell Therapy—Commercially Available Products by Therapy
Overview of Competing Products—By Development and Key Participants
Commercially Available Primary Cell Therapy and Allograft Products
Commercially Available Primary Cell Therapy and Allograft Products (continued)
Cellular Dynamics International (CDI), Madison, Wisconsin
Orthofix International, Lewisville, Texas
Capricor Therapeutics, Beverly Hills, California
Big Pharmaceuticals and Regenerative Medicine
Market Drivers and Restraints for Stem Cell Manufacturing
Stem Cell Consumer Information—The United States
Stem Cell Consumer Information—Global
Future Trends
Market Opportunities
Global Partnerships and Deals for Regenerative Medicine
Key Global Partnerships and Deals for Regenerative Medicine
Regenerative Medicine Market—Funding Scenario
Regenerative Medicine—Asia-Pacific Market Overview
Regenerative Medicine—Leading APAC Countries
Regenerative Medicine—Leading APAC Countries(continued)
Regenerative Medicine—Lifecycle for Leading APAC Countries
Regenerative Medicine—South Korea
Regenerative Medicine—China
Regenerative Medicine—Japan
Regenerative Medicine—Singapore
Regenerative Medicine—Key Market Access Barriers
Successful Stem Cell Therapy Company—MEDIPOST Co., Ltd.
Successful Stem Cell Therapy Company—Mesoblast Ltd.
The Last Word
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Jane Andrews, Ph.D. |
| WIP Number | 9AB9-00-3D-00-00 |
| Is Prebook | No |
The New Age of Regenerative Medicine
$1,500.00
Special Price $1,125.00 save 25 %